These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15917284

  • 1. Efficacy of Abelcet and caspofungin, alone or in combination, against CNS aspergillosis in a murine model.
    Imai J, Singh G, Fernandez B, Clemons KV, Stevens DA.
    J Antimicrob Chemother; 2005 Jul; 56(1):166-71. PubMed ID: 15917284
    [Abstract] [Full Text] [Related]

  • 2. Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
    Wasan KM, Sivak O, Rosland M, Risovic V, Bartlett K.
    J Pharm Sci; 2007 Jul; 96(7):1737-47. PubMed ID: 17080414
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis.
    Clemons KV, Parmar R, Martinez M, Stevens DA.
    J Antimicrob Chemother; 2006 Aug; 58(2):466-9. PubMed ID: 16760192
    [Abstract] [Full Text] [Related]

  • 4. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis.
    Sivak O, Bartlett K, Risovic V, Choo E, Marra F, Batty DS, Wasan KM.
    J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198
    [Abstract] [Full Text] [Related]

  • 5. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
    Clemons KV, Espiritu M, Parmar R, Stevens DA.
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
    [Abstract] [Full Text] [Related]

  • 6. Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
    Clemons KV, Schwartz JA, Stevens DA.
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4439-49. PubMed ID: 22687510
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
    Clemons KV, Stevens DA.
    Med Mycol; 2006 Feb; 44(1):69-73. PubMed ID: 16805095
    [Abstract] [Full Text] [Related]

  • 10. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II, Hanna HA, Boktour M, Jiang Y, Torres HA, Afif C, Kontoyiannis DP, Hachem RY.
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
    van Vianen W, de Marie S, ten Kate MT, Mathot RA, Bakker-Woudenberg IA.
    J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
    [Abstract] [Full Text] [Related]

  • 14. Nebulized liposomal amphotericin B and combined systemic antifungal therapy for the treatment of severe pulmonary aspergillosis after allogeneic hematopoietic stem cell transplant for a fatal mitochondrial disorder.
    Castagnola E, Moresco L, Cappelli B, Cuzzubbo D, Moroni C, Lanino E, Faraci M.
    J Chemother; 2007 Jun; 19(3):339-42. PubMed ID: 17594932
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP.
    Am J Health Syst Pharm; 2003 Nov 15; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.